Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway

Although the efficacy of celecoxib on various cancer cell behaviors, including aberrant proliferation, in cultured hepatocellular carcinoma (HCC) cells has been demonstrated, whether celecoxib regulates cell proliferation by targeting PRL-3-associated signaling transduction during hepatocarcinogenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cong, Zhou, Junxuan, Hu, Junjie, Lei, Sheng, Yuan, Ming, Chen, Liang, Wang, Guihong, Qiu, Zhenpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065693/
https://www.ncbi.nlm.nih.gov/pubmed/35515542
http://dx.doi.org/10.1039/c9ra00429g

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065693/
https://www.ncbi.nlm.nih.gov/pubmed/35515542
http://dx.doi.org/10.1039/c9ra00429g

Ejemplares similares